Individuals living with type 2 diabetes (T2D) had a significantly lower risk of poor cardiovascular health when they used a GLP-1 receptor agonist (GLP-1 RA) in combination with adhering to healthy lifestyle …Read More
GLP-1 drugs combined with healthy lifestyle habits linked to reduced cardiovascular risk among diabetes patients
Related Posts
Add A Comment
